Estery GilozRan - Kamada Independent Director
| KMDA Stock | ILA 2,190 29.00 1.31% |
Director
Dr. Estery GilozRan serves as Independent Director at Kamada Ltd. She has served on our board of directors since January 2014 and is an external director within the meaning of the Companies Law. During 2013 Dr. GilozRan was a Visiting Scholar at the New York University in the Department of Accounting, as well as a Visiting Assistant Professor of Finance in the Sy Syms School of Business at the Yeshiva University in New York City. From 2010 to 2014, Dr. GilozRan was also the Head of Accountancy at the Peres Academic Center in the Accounting and Business Administration Department and a lecturer at BenGurion University, teaching courses in finance, taxes and accounting. From 2008 to 2010, Dr. GilozRan was a tax consultant and tax capital investment law adviser at Intel Corporation in Israel. Dr. GilozRan holds a PhD in tax and accounting and an M.B.A. degree, both from Ben Gurion University, and a B.A. degree in Business Management from the Open University. Dr. GilozRan completed her PostDoctorate as Visiting Scholar at New York University in the Leonard N. Stern School of Business in 2014. Dr. GilozRan in a certified public accountant . since 2014.
| Age | 44 |
| Tenure | 10 years |
| Phone | (972) 8 9406472 |
| Web | www.kamada.com |
Kamada Management Efficiency
Kamada's management efficiency ratios could be used to measure how well Kamada manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Yoram BenZeev | Elbit Systems | 74 | |
| Nechemia Peres | Teva Pharmaceutical Industries | 60 | |
| Gerald Lieberman | Teva Pharmaceutical Industries | 72 | |
| Kalman Kaufman | Tower Semiconductor | 72 | |
| Roberto Mignone | Teva Pharmaceutical Industries | 47 | |
| Ilan Flato | Tower Semiconductor | 61 | |
| Avraham Guzman | Tower Semiconductor | 79 | |
| Dov Ninveh | Elbit Systems | 71 | |
| Yehoshua Gleitman | Elbit Systems | 69 | |
| Perry Nisen | Teva Pharmaceutical Industries | 63 | |
| Rina Baum | Elbit Systems | 73 | |
| Rosemary Crane | Teva Pharmaceutical Industries | 59 | |
| Ehood Nisan | Elbit Systems | 51 | |
| JeanMichel Halfon | Teva Pharmaceutical Industries | 67 | |
| Dana Gross | Tower Semiconductor | 51 | |
| Alex Kornhauser | Tower Semiconductor | 71 | |
| Yuli Tamir | Elbit Systems | 65 | |
Management Performance
| Return On Equity | -0.058 | |||
| Return On Asset | -0.0023 |
Kamada Leadership Team
Elected by the shareholders, the Kamada's board of directors comprises two types of representatives: Kamada inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kamada. The board's role is to monitor Kamada's management team and ensure that shareholders' interests are well served. Kamada's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kamada's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pnina Strauss, Vice President - Inhalation programs & IP | ||
| Itzhak Krinsky, Director | ||
| Lilach Topilsky, Chairman of the Board | ||
| Ari Shamiss, Director | ||
| Barak Bashari, Vice President - Operations | ||
| Eran Schenker, Vice President - Medical Director | ||
| Tuvia Shoham, Independent Director | ||
| Eran Nir, Chief Officer | ||
| Hanni Neheman, VP Sales | ||
| Michal Stein, Vice President and Medical Director for Immunology | ||
| Ariella Raban, VP HR | ||
| Shani Dotan, Vice President of Human Resources | ||
| Yael Brenner, Vice President - Quality | ||
| Abraham Havron, Independent Director | ||
| Ruth Wolfson, Senior Vice President - Scientific Affairs | ||
| Shmuel Rubinstein, Director | ||
| Naveh Tov, Vice President-Clinical Development and Medical Director for Pulmonary Diseases | ||
| Jon Knight, VP Operations | ||
| Michael Berelowitz, Director | ||
| David Tsur, Co-Founder and Deputy Executive Chairman | ||
| Orit Pinchuk, Vice President - Regulatory Affairs and Quality R&D | ||
| Leon Recanati, Chairman of the Board | ||
| Jonathan Hahn, Director | ||
| Gwen Melincoff, Director | ||
| Chaime Orlev, Chief Financial Officer | ||
| Michal Ayalon, Vice President - Research & Development | ||
| Yifat Esq, Gen Legal | ||
| Amir London, Chief Executive Officer | ||
| Estery GilozRan, Independent Director | ||
| Eitan Kyiet, Vice President - Business Development |
Kamada Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kamada a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.058 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 636.38 M | |||
| Shares Outstanding | 44.8 M | |||
| Shares Owned By Insiders | 18.50 % | |||
| Shares Owned By Institutions | 32.04 % | |||
| Price To Book | 1.13 X | |||
| Price To Sales | 5.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Kamada Stock
When determining whether Kamada offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kamada's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kamada Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kamada Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kamada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.